Analysis of potential predictive factors of clinical benefit in patients (pts) with metastatic colorectal cancer (MCRC) treated with single-agent cetuximab as first-line treatment

Cristina Grávalos,Javier Sastre,Enrique Aranda,B. Massuti,Maria Eugenia Vega-Villegas,A. Gomez,Marileila Varella-Garcia,Antonio Jimeno,E. Díaz Rubio,M. Hidalgo

Analysis of potential predictive factors of clinical benefit in patients (pts) with metastatic colorectal cancer (MCRC) treated with single-agent cetuximab as first-line treatment

2016

Cristina Grávalos
Javier Sastre
Enrique Aranda
B. Massuti
Maria Eugenia Vega-Villegas
A. Gomez
Marileila Varella-Garcia
Antonio Jimeno
E. Díaz Rubio
M. Hidalgo

4120 Background: Our group has recently shown that single-agent cetuximab in first-line treatment of elderly MCRC pts has a favorable safety profile and similar activity to that observed in pretrea...

Keywords:

Colorectal cancer
Pathology
Oncology
Cetuximab
Internal medicine
Medicine
first line treatment
safety profile
single agent
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations